Leerink Partners provided coverage and price targets for Freenome on September 26, 2026.
1 report, 1 independent
Updated Sat 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink Partners provided coverage and price targets for Freenome on September 26, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Leerink partners
U.S. investment bank
Related events
- An analyst firm has provided price target recommendations for Universal Health Services.
- Leerink Partners started coverage on ANI Pharmaceuticals shares.
- Needham & Company issued a buy rating, and Leerink Partners began coverage of Collegium Pharmaceutical, Inc. on September 23, 2026.
- Leerink partners, TD Cowen, and William Blair initiated coverage and set ratings for Kailera Therapeutics.
- Leerink raised its price target for UnitedHealth Group stock.